Angelo Avogaro1, Francesco Barillà2, Franco Cavalot3, Agostino Consoli4, Massimo Federici2, Massimo Mancone5, Stefania Paolillo6, Roberto Pedrinelli7, Gianluca Perseghin8, Pasquale Perrone Filardi6, Roberto Scicali9, Gianfranco Sinagra10, Carmen Spaccarotella11, Ciro Indolfi12, Francesco Purrello13. 1. Dipartimento di Medicina, Sezione di Diabete e Malattia del Metabolismo, Università di Padova, Italy. 2. Dipartimento di Medicina dei Sistemi, Università di Roma Tor Vergata, Italy. 3. SSD Malattie Metaboliche e Diabetologia, AOU San Luigi Gonzaga, Orbassano (Torino), Italy. 4. Department of Medicine and Ageing Sciences and CeSI-Met, University D'Annunzio, Chieti, Italy. 5. Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Policlinico Umberto I (Roma), Italy. 6. Dipartimento di Scienze Biomediche Avanzate, Sezione di Cardiologia, Università degli Studi di Napoli Federico II, Italy; Mediterranea Cardiocentro, Napoli, Italy. 7. Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, Università di Pisa, Italy. 8. Dipartimento di Medicina e Riabilitazione, Policlinico di Monza, Università degli Studi di Milano Bicocca, Italy. 9. Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Italy. 10. Cardiovascular Department 'Ospedali Riuniti' and University of Trieste, Trieste, Italy. 11. Division of Cardiology, University Magna Graecia, Catanzaro, Italy. 12. Division of Cardiology, University Magna Graecia, Catanzaro, Italy; Mediterranea Cardiocentro, Napoli, Italy. Electronic address: indolfi@unicz.it. 13. Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Italy. Electronic address: francesco.purrello@unict.it.
Abstract
AIM: This review represents a joint effort of the Italian Societies of Cardiology (SIC) and Diabetes (SID) to define the state of the art in a field of great clinical and scientific interest which is experiencing a moment of major cultural advancements, the cardiovascular risk management in type 2 diabetes mellitus. DATA SYNTHESIS: Consists of six chapters that examine various aspects of pathophysiology, diagnosis and therapy which in recent months have seen numerous scientific innovations and several clinical studies that require extensive sharing. CONCLUSIONS: The continuous evolution of our knowledge in this field confirms the great cultural vitality of these two cultural spheres, which requires, under the leadership of the scientific Societies, an ever greater and effective collaboration.
AIM: This review represents a joint effort of the Italian Societies of Cardiology (SIC) and Diabetes (SID) to define the state of the art in a field of great clinical and scientific interest which is experiencing a moment of major cultural advancements, the cardiovascular risk management in type 2 diabetes mellitus. DATA SYNTHESIS: Consists of six chapters that examine various aspects of pathophysiology, diagnosis and therapy which in recent months have seen numerous scientific innovations and several clinical studies that require extensive sharing. CONCLUSIONS: The continuous evolution of our knowledge in this field confirms the great cultural vitality of these two cultural spheres, which requires, under the leadership of the scientific Societies, an ever greater and effective collaboration.